Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0KYLAF |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | IN202417078684A+Ab1 |
|||||
| Organization | TAIHO PHARMACEUTICAL CO., LTD. |
|||||
| Synonyms |
IN202417078684A+Ab1
Click to Show/Hide
|
|||||
| Antibody Type | Ph-dependent Anti-sulfated glycosaminoglycan antibody |
|||||
| Antibody Subtype | IgH |
|||||
| Antigen Name | Undisclosed |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
| Heavy Chain Varible Domain |
QVQLQESGPGLVKPSETLSLTCTVSGGFITSHHWSWIRQPPGQGLEWIGFLHHTGTTHYN
PSLKSRVTTSVDTAKNQFSLTLKSLTAADTAVYYCVREDSSSWHPGRYIQLWGQGTLVTV SAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQ SSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELL GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQ YNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSR DELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKS RWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK Click to Show/Hide
|
|||||
| Light Chain Varible Domain |
DVVMTQSPLSLPVTPGEPASISCRSSQSLLQNNRYNRFDWYLQKPGQSPRILIYLGSNRA
SGVPDRFSGTTSGTDYTLRISRVEAEDAGVYYCMHALEPPYTFGQGTKLEIKRTVAAPSV FIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSL SSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC Click to Show/Hide
|
|||||
| Light Chain CDR 1 |
GGFITSHH
Click to Show/Hide
|
|||||
| Light Chain CDR 2 |
LHHTGTT
Click to Show/Hide
|
|||||
| Light Chain CDR 3 |
VREDSSSWHPGRYIQL
Click to Show/Hide
|
|||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
IN202417078684A+ADC1 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
240 ng/ml
|
|||
| Method Description |
The cytotoxicity of ADC against cell lines was evaluated by cell viability test with CellTiter-Glo 2.0 luminescence method.
|
||||
